Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nokia Corp (NOK) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Nokia CorpTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Nokia Corp vs Recursion Pharmaceuticals Inc — how do they compare? Nokia Corp trades at $10.21 (market cap $53.00B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Nokia Corp is far larger — about 29.3× Recursion Pharmaceuticals Inc's market cap, and Nokia Corp pays a 1.73% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

NOKRXRX
Market Cap
$53.00B$1.81B
Sector
TechnologyHealth
52-Week High
$16.83$6.79
52-Week Low
$4.13$2.84
Enterprise Value
$50.95B$1.33B
Dividend Yield
1.73%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nokia Corp

Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.

Read more on NOK

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX